↓ Skip to main content

Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer

Overview of attention for article published in Pharmaceutical Research, September 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent
10 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
193 Dimensions

Readers on

mendeley
118 Mendeley
citeulike
1 CiteULike
Title
Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer
Published in
Pharmaceutical Research, September 2009
DOI 10.1007/s11095-009-9964-5
Pubmed ID
Authors

Fancy C. Thomas, Kunal Taskar, Vinay Rudraraju, Satyanarayana Goda, Helen R. Thorsheim, Julie A. Gaasch, Rajendar K. Mittapalli, Diane Palmieri, Patricia S. Steeg, Paul R. Lockman, Quentin R. Smith

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Netherlands 1 <1%
Unknown 115 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 29 25%
Researcher 26 22%
Student > Master 15 13%
Student > Doctoral Student 6 5%
Student > Bachelor 6 5%
Other 23 19%
Unknown 13 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 25 21%
Medicine and Dentistry 22 19%
Biochemistry, Genetics and Molecular Biology 15 13%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Neuroscience 6 5%
Other 23 19%
Unknown 20 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2023.
All research outputs
#3,919,343
of 26,017,215 outputs
Outputs from Pharmaceutical Research
#286
of 3,134 outputs
Outputs of similar age
#13,902
of 110,766 outputs
Outputs of similar age from Pharmaceutical Research
#1
of 23 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,134 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,766 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.